Tenderwize
Retour à la recherche

Open House Originale Agreement for Ponesimod

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 430 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-26 - Ponesimod

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

Offers/contracts cannot be submitted through the procurement portal; they must be sent by email with qualified electron...

Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal product and requires the stated AMG...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Supply arrangement for pharmaceutical products concerning the active substance Ponesimod.
  • Open House original rebate contracts under Section 130c(1) SGB V.
Afficher le résumé complet

This is a German Open House supply arrangement for pharmaceutical products, specifically Ponesimod, led by Techniker Krankenkasse with participating sickness funds. It is not a classic competitive award procedure: all suitable pharmaceutical companies meeting the stated conditions may join during the contract period. No estimated contract value is provided. The contract runs from 01.11.2025 to 31.10.2027 at the latest, with automatic earlier end if patent/market exclusivity expires. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the participation documents are only available electronically on the portal.

Risques

Offers/contracts cannot be submitted through the procurement portal; they must be sent by email with qualified electron...

Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal product and requires the stated AMG...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Agreement for Ponesimod

Single lot for an Open House original rebate agreement for the active substance Ponesimod. Scope is nationwide in Germany. The arrangement is open to all suitable pharmaceutical companies that meet the stated legal and self-declaration requirements. No exclusivity and no individual negotiation apply. The lot information comes from structured data and the notice text.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Oct 2025 - Oct 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Oct 30, 2027

Détails de la procédure

Date de publication
08 Sep 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
586433-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3